Observations in ccRCC revealed that loss-of-function mutations of BAP1 upregulated the immunosuppressive gene CCR5, resulting in resistance to immune checkpoint blockade (ICB) therapy [12]. The gene discussed is BAP1; the disease is nonpapillary renal cell carcinoma.